Navigation and service

You are here:Homepage

Parallel Imports

Pharmaceutical entrepreneurs market many of their medicinal products both in Germany and in other Member States of the European Union (EU) and/or the European Economic Area (EEA). For each of these medicinal products they have a separate national marketing authorisation from the corresponding Member State.

Such medicinal products are called parallel imported medicinal products if a company that is independent of the original marketing authorisation holder or manufacturer purchases them in another Member State of the EU or EEA and imports them to Germany, in order to place them on the market there as well – parallel to the original pharmaceutical entrepreneur.

Medicinal products that are licensed and marketed outside the EU or EEA cannot be parallel imported.